HVC
Healthcare Value Capital Portfolio holdings
AUM
$38.5M
1-Year Return
22.29%
This Quarter Return
+1.69%
1 Year Return
+22.29%
3 Year Return
+31.09%
5 Year Return
+125.72%
10 Year Return
–
AUM
$69.2M
AUM Growth
+$2.24M
(+3.3%)
Cap. Flow
+$2.17M
Cap. Flow
% of AUM
3.13%
Top 10 Holdings %
Top 10 Hldgs %
83.36%
Holding
32
New
3
Increased
5
Reduced
5
Closed
5
Top Buys
| 1 |
ANI Pharmaceuticals
ANIP
|
$7.76M |
| 2 |
QLTI
QLT Inc
QLTI
|
$4.94M |
| 3 |
Artivion
AORT
|
$1.68M |
| 4 |
AbbVie
ABBV
|
$1.68M |
| 5 |
ADYX
Adynxx, Inc. Common Stock
ADYX
|
$1.19M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$6.23M |
| 2 |
Ligand Pharmaceuticals
LGND
|
$3.86M |
| 3 |
ProShares UltraShort Russell2000
TWM
|
$3.48M |
| 4 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
$1.32M |
| 5 |
Quest Diagnostics
DGX
|
$798K |
Sector Composition
| 1 | Healthcare | 73.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
MannKind Corp
MNKD
$1.73B
| – | – |
0
| – | – |
|
27
Rigel Pharmaceuticals
RIGL
$722M
| – | – |
-15,000
| Closed | -$536K |
|
28
Sanofi
SNY
$114B
| – | – |
0
| – | – |
|
29
Supernus Pharmaceuticals
SUPN
$2.58B
| – | – |
0
| – | – |
|
|
30
Teva Pharmaceuticals
TEVA
$21.5B
| – | – |
-100,000
| Closed | -$6.23M |
|
31
ProShares VIX Short-Term Futures ETF
VIXY
$86.4M
| – | – |
0
| – | – |
|
32
Xoma
XOMA
$426M
| – | – |
0
| – | – |
|